Pediatric Respiratory Infections Back to Pre-Pandemic Patterns
Pediatric influenza and Mycoplasma pneumoniae infections returned to pre-pandemic levels after COVID-19 restrictions were lifted.
Pediatric influenza and Mycoplasma pneumoniae infections returned to pre-pandemic levels after COVID-19 restrictions were lifted.
Specific host genotypes and sexes can cause influenza A viruses to gain virulence faster, potentially impacting the severity of flu outbreaks.
The AMDI Fast PCR System provides point-of-care results for RSV, influenza, and COVID-19 in less than 10 minutes.
Backed by approximately $500 million in investment from Big Tech, the Intercept initiative will back broad-spectrum preventatives and air-cleaning technologies to reduce the global health burden of respiratory infections.
Real-world data published in JAMA Network Open confirm the effectiveness of the RSVpreF vaccine in protecting newborns from respiratory syncytial virus.
On June 21, HHS ended the final 42-day monitoring period following potential exposure on the M/V Hondius cruise ship, reporting no sustained transmission within the country.